Lindis Blood Care raises €5.0M Series A round
11 December 2019· Hennigsdorf, Germany· health, biotech, b2b, deep_hardware, medical_devices
To secure the clinical development of the CATUVAB medical device and take the company through the final phase of development for the removal of tumor cells from surgical blood.
Investors
LeadHigh-Tech Gründerfonds
Also participating
Brandenburg Kapital
About Lindis Blood Care
Stage
Series B
Headquarters
Hennigsdorf, Germany
Founded
2018
Team Size
21–50
Sectors
healthbiotechb2bdeep_hardwaremedical_devices
Source: https://www.htgf.de/en/over-5-million-euros-for-lindis-blood-care/